Skip to main content
. Author manuscript; available in PMC: 2015 Jan 27.
Published in final edited form as: Neuroscience. 2007 May 2;146(4):1546–1554. doi: 10.1016/j.neuroscience.2007.03.006

Table 2.

Characterization of opioid receptor immunoreactivity in glial restricted precursors at 5 DIV.

Developmental marker Opioid receptor Percentage (%) co-localized with opioid receptors*
Sox2 MOR 87.9 ± 4.4
DOR 90.5 ± 1.4
KOR 93.9 ± 3.4
Nkx2.2 MOR 88.2 ± 4.0
DOR 77.8 ± 10.7
KOR 69.0 ± 13.1
*

The proportion of Sox2 or Nkx2.2 immunoreactive glial precursors that expressed μ (MOR), δ (DOR), or k (KOR) opioid receptors at 5 DIV. Mean ± SEM from 3-4 experiments and approximately 100 cells per group were sampled in each experiment.